TNB TopicalNewsBeats

Crypto, chains and markets — the beat, as it happens

LIVE
CointelegraphUS sanctions Iran’s BitBank, saying it processes ‘Hormuz Safe’… Bitcoin MagazineDan Hillery: Digital Credit Could Rival BTC’s $1.5 Trillion Market Cap CointelegraphNorth Korea drives onchain malware surge, CoinEx shuts: Asia Express DecryptOpenAI Models Are Writing Their Own Jailbreak Instructions—And… Bitcoin MagazineTreasury Sanctions Iranian Crypto Exchange BitBank Over Bitcoin… CoinDeskReal stocks are finally coming on blockchain. Here’s how the SEC… DecryptSecurity Experts Want the US and China to Promise Never to Let AI… CoinDeskThe Ondo Finance succession crisis gets messier as Kathleen Allman’s… CointelegraphUS sanctions Iran’s BitBank, saying it processes ‘Hormuz Safe’… Bitcoin MagazineDan Hillery: Digital Credit Could Rival BTC’s $1.5 Trillion Market Cap CointelegraphNorth Korea drives onchain malware surge, CoinEx shuts: Asia Express DecryptOpenAI Models Are Writing Their Own Jailbreak Instructions—And… Bitcoin MagazineTreasury Sanctions Iranian Crypto Exchange BitBank Over Bitcoin… CoinDeskReal stocks are finally coming on blockchain. Here’s how the SEC… DecryptSecurity Experts Want the US and China to Promise Never to Let AI… CoinDeskThe Ondo Finance succession crisis gets messier as Kathleen Allman’s…

Decrypt

Moderna Stock Doubles on Cancer Breakthrough: Here’s What It Means

A Phase 3 win against the standard of care sent the biotech's shares up 131% and left short sellers down $4.8 billion.

Photo: Decrypt

A Phase 3 win against the standard of care sent the biotech's shares up 131% and left short sellers down $4.8 billion.

Originally published by Decrypt. Read the full story at the source →

More stories